CompuMed, Inc. provides diagnostic telemedicine solutions. Its telecardiology and teleradiology solutions provide direct access to United States Board-Certified specialists through cloud-based technology and integrated medical devices. Its solutions support the diagnosis and treatment of high incidence diseases, including cardiovascular disease. It has established a network for remote electronic processing of electrocardiograms (ECGs), echocardiograms, ultrasound studies and X-rays. It has also created an electronic telemedicine infrastructure to link clinical diagnostic equipment data collected at the patientâs point of care with top specialists. It also provides real-time access to specialists for consultations. It is also providing single lead ECG interpretations for the consumer market through a handheld device. Its services are available 24 hours a day, seven days per week. It contracts with certain partners to develop diagnostic systems, which support its telemedicine workflow.
CompuMed, Inc.'s Equity Buyback announced on June 12, 2023, has closed with 362,168 shares, representing 21.57% for $0.72 million.
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**All transcripts on over 9000 companies, on the day they post their earnings!**#ffffff**/services/solutions/**#004EFF**#000000**Unlock them now!**1**